From FDA-Cleared Wearables to AI Caregivers: Rune Labs CEO on Closing the Gap in Parkinson's Care

For the nearly one million Americans living with Parkinson's disease, the space between neurology appointments can feel like a void — symptoms shift, medications need adjusting, and urgent questions pile up with nowhere to turn. That gap in continuous care is exactly the problem Rune Labs set out to solve. With its StrivePD app, Rune Labs has built a platform powered by FDA-cleared movement analysis and one of the largest real-world Parkinson's datasets in existence. Now, the company is going further — launching an AI caregiver directly inside the app: a coordinated system of specialized AI agents, including a Medication Assistant, Symptom Expert, and PD Coach, that deliver personalized, evidence-based guidance based on each patient's own real-time data. In this episode of Digital Health Talks, host Megan Antonelli sits down with Amy Gordon Franzen, the new CEO of Rune Labs, to explore how the company is redefining what it means to support patients not just in the clinic, but every moment of every day. From the science behind the platform to the policy, trust, and ethical questions that come with deploying AI in a chronic disease setting, this is a conversation about what the future of neurological care can actually look like — and who gets to shape it. Amy Gordon Franzen, CEO, Rune Labs Megan Antonelli, Chief Executive Officer, HealthIMPACT